Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression

Autoimmune diseases are driven by chronic inflammation and oxidative stress, thus requiring innovative therapeutic approaches. Polymeric nanotherapeutics incorporating antioxidant bioactive compounds offer a promising strategy for immune modulation and enhanced drug delivery. This review explores th...

Full description

Saved in:
Bibliographic Details
Main Authors: Panagiotis Theodosis-Nobelos, Fani-Niki Varra, Michail Varras, Georgios Papagiouvannis, Eleni A. Rekka
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/6/411
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467454893326336
author Panagiotis Theodosis-Nobelos
Fani-Niki Varra
Michail Varras
Georgios Papagiouvannis
Eleni A. Rekka
author_facet Panagiotis Theodosis-Nobelos
Fani-Niki Varra
Michail Varras
Georgios Papagiouvannis
Eleni A. Rekka
author_sort Panagiotis Theodosis-Nobelos
collection DOAJ
description Autoimmune diseases are driven by chronic inflammation and oxidative stress, thus requiring innovative therapeutic approaches. Polymeric nanotherapeutics incorporating antioxidant bioactive compounds offer a promising strategy for immune modulation and enhanced drug delivery. This review explores the application of polymer-based nanocarriers for improving the solubility, bioavailability, and targeted delivery of antioxidant compounds in autoimmune disease treatment. A comprehensive analysis of recent advancements in polymeric nanoformulations, including poly(lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG), chitosan, and hyaluronic acid, was conducted. The therapeutic efficacy of various antioxidant-loaded nanoparticles has been assessed in both preclinical and clinical studies. Phenolic antioxidants, such as resveratrol, curcumin, quercetin, and epigallocatechin-3-gallate, exhibit potent anti-inflammatory effects; however, their poor solubility limits their clinical application. Nanocarriers such as dendrosomes, tannic acid-based reactive oxygen species (ROS)-scavenging nanoparticles, and folic acid-functionalized systems enhance drug stability, controlled drug release, and macrophage targeting. Carotenoid and bilirubin nanoparticles further demonstrate immunomodulatory effects in multiple sclerosis, psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Polymeric antioxidant nanotherapeutics provide targeted and sustained drug delivery, offering improved efficacy and reduced toxicity. Future research should focus on optimizing these nanocarriers for clinical translation and patient-centered therapeutic strategies.
format Article
id doaj-art-8621faceebb1400eba5aa8b90d484c80
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-8621faceebb1400eba5aa8b90d484c802025-08-20T03:26:11ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-06-0147641110.3390/cimb47060411Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases ProgressionPanagiotis Theodosis-Nobelos0Fani-Niki Varra1Michail Varras2Georgios Papagiouvannis3Eleni A. Rekka4Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, CyprusMedical School, Democritus University of Thrace, 68100 Alexandroupolis, GreeceFourth Department of Obstetrics and Gynecology, ‘Elena Venizelou’ General Hospital, 11521 Athens, GreeceDepartment of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, CyprusDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceAutoimmune diseases are driven by chronic inflammation and oxidative stress, thus requiring innovative therapeutic approaches. Polymeric nanotherapeutics incorporating antioxidant bioactive compounds offer a promising strategy for immune modulation and enhanced drug delivery. This review explores the application of polymer-based nanocarriers for improving the solubility, bioavailability, and targeted delivery of antioxidant compounds in autoimmune disease treatment. A comprehensive analysis of recent advancements in polymeric nanoformulations, including poly(lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG), chitosan, and hyaluronic acid, was conducted. The therapeutic efficacy of various antioxidant-loaded nanoparticles has been assessed in both preclinical and clinical studies. Phenolic antioxidants, such as resveratrol, curcumin, quercetin, and epigallocatechin-3-gallate, exhibit potent anti-inflammatory effects; however, their poor solubility limits their clinical application. Nanocarriers such as dendrosomes, tannic acid-based reactive oxygen species (ROS)-scavenging nanoparticles, and folic acid-functionalized systems enhance drug stability, controlled drug release, and macrophage targeting. Carotenoid and bilirubin nanoparticles further demonstrate immunomodulatory effects in multiple sclerosis, psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Polymeric antioxidant nanotherapeutics provide targeted and sustained drug delivery, offering improved efficacy and reduced toxicity. Future research should focus on optimizing these nanocarriers for clinical translation and patient-centered therapeutic strategies.https://www.mdpi.com/1467-3045/47/6/411autoimmune diseaseoxidative stressantioxidant bioactive compoundsinflammationtargeted drug deliverypharmacokinetic improvement
spellingShingle Panagiotis Theodosis-Nobelos
Fani-Niki Varra
Michail Varras
Georgios Papagiouvannis
Eleni A. Rekka
Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
Current Issues in Molecular Biology
autoimmune disease
oxidative stress
antioxidant bioactive compounds
inflammation
targeted drug delivery
pharmacokinetic improvement
title Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
title_full Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
title_fullStr Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
title_full_unstemmed Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
title_short Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression
title_sort antioxidant naturally occurring pleiotropically acting bioactive compounds as polymeric nanotherapeutics against autoimmune diseases progression
topic autoimmune disease
oxidative stress
antioxidant bioactive compounds
inflammation
targeted drug delivery
pharmacokinetic improvement
url https://www.mdpi.com/1467-3045/47/6/411
work_keys_str_mv AT panagiotistheodosisnobelos antioxidantnaturallyoccurringpleiotropicallyactingbioactivecompoundsaspolymericnanotherapeuticsagainstautoimmunediseasesprogression
AT faninikivarra antioxidantnaturallyoccurringpleiotropicallyactingbioactivecompoundsaspolymericnanotherapeuticsagainstautoimmunediseasesprogression
AT michailvarras antioxidantnaturallyoccurringpleiotropicallyactingbioactivecompoundsaspolymericnanotherapeuticsagainstautoimmunediseasesprogression
AT georgiospapagiouvannis antioxidantnaturallyoccurringpleiotropicallyactingbioactivecompoundsaspolymericnanotherapeuticsagainstautoimmunediseasesprogression
AT eleniarekka antioxidantnaturallyoccurringpleiotropicallyactingbioactivecompoundsaspolymericnanotherapeuticsagainstautoimmunediseasesprogression